{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:11:23Z","timestamp":1787886683099,"version":"build-2784847793"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR002346"],"award-info":[{"award-number":["KL2TR002346"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DE029514"],"award-info":[{"award-number":["K23DE029514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007172"],"award-info":[{"award-number":["T32AI007172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Persons who inject drugs (PWID) are frequently admitted for serious injection-related infections (SIRIs). PWID are also at risk for sexually transmitted infections (STIs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a multicenter quality improvement project at 3 hospitals in Missouri. PWID with SIRI who received an infectious diseases consultation were prospectively identified and placed into an electronic database as part of a Centers for Disease Control and Prevention\u2013funded quality improvement project. Baseline data were collected from 8\/1\/2019 to 1\/30\/2020. During the intervention period (2\/1\/2020\u20132\/28\/2021), infectious diseases physicians caring for patients received 2 interventions: (1) email reminders of best practice screening for HIV, viral hepatitis, and STIs; (2) access to a customized EPIC SmartPhrase that included checkboxes of orders to include in assessment and plan of consultation notes. STI screening rates were compared before and after the intervention. We then calculated odds ratios to evaluate for risk factors for STIs in the cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three hundred ninety-four unique patients were included in the cohort. Initial screening rates were highest for hepatitis C (88%), followed by HIV (86%). The bundled intervention improved screening rates for all conditions and substantially improved screening rates for gonorrhea, chlamydia, and syphilis (30% vs 51%, 30% vs 51%, and 39 vs 60%, respectively; P\u2005&amp;lt;\u2005.001). Of patients who underwent screening, 16.9% were positive for at least 1 STI. In general, demographics were not strongly associated with STIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>PWID admitted for SIRI frequently have unrecognized STIs. Our bundled intervention improved STI screening rates, but additional interventions are needed to optimize screening.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofab489","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T18:13:26Z","timestamp":1637172806000},"source":"Crossref","is-referenced-by-count":19,"title":["Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-443X","authenticated-orcid":false,"given":"Laura R","family":"Marks","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-5492","authenticated-orcid":false,"given":"Hilary","family":"Reno","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y","family":"Liang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"},{"name":"Department of Emergency Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"},{"name":"Division of Medical Toxicology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Liss","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"},{"name":"Division of Medical Toxicology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Medical Education, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial S","family":"Nolan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Durkin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"2021111718053264100_CIT0001","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2021111718053264100_CIT0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015-2018.","volume":"110","author":"Alpren","year":"2020","journal-title":"Am J Public Health"},{"key":"2021111718053264100_CIT0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious diseases and injection drug use: public health burden and response.","volume":"222","author":"Levitt","year":"2020","journal-title":"J Infect Dis"},{"key":"2021111718053264100_CIT0004","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-12.","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff"},{"key":"2021111718053264100_CIT0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","article-title":"A systematic review of injecting-related injury and disease among people who inject drugs.","volume":"171","author":"Larney","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2021111718053264100_CIT0006","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012\u20132017.","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021111718053264100_CIT0007","doi-asserted-by":"crossref","first-page":"339","DOI":"10.12788\/jhm.2736","article-title":"Planning and designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder.","volume":"12","author":"Englander","year":"2017","journal-title":"J Hosp Med"},{"key":"2021111718053264100_CIT0008","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder.","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021111718053264100_CIT0009","article-title":"Recent HIV clusters and outbreaks across the United States among people who inject drugs and considerations during the COVID-19 pandemic.","author":"CDC Health Alert Network","year":"2020","journal-title":"Health Alert Network. 5 October"},{"key":"2021111718053264100_CIT0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-159-1-201307020-00645","article-title":"Screening for HIV: U.S. Preventive Services Task Force recommendation statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"2021111718053264100_CIT0011","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10461-012-0276-0","article-title":"Non-injection and injection drug use and STI\/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.","volume":"17","author":"Khan","year":"2013","journal-title":"AIDS Behav"},{"issue":"Suppl 5","key":"2021111718053264100_CIT0012","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1093\/infdis\/jiaa056","article-title":"The emerging intersection between injection drug use and early syphilis in nonurban areas of Missouri, 2012-2018.","volume":"222","author":"Reno","year":"2020","journal-title":"J Infect Dis"},{"key":"2021111718053264100_CIT0013","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007435-199607000-00006","article-title":"History of sexually transmitted diseases infection, drug-sex behaviors, and the use of condoms among Midwestern users of injection drugs and crack cocaine.","volume":"23","author":"Siegal","year":"1996","journal-title":"Sex Transm Dis"},{"key":"2021111718053264100_CIT0014","doi-asserted-by":"crossref","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: a national study.","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"2021111718053264100_CIT0015","volume-title":"At 30 years: HIV\/AIDS and other STDs among persons who use psychoactive drugs","author":"Des Jarlais"},{"key":"2021111718053264100_CIT0016","year":"2018"},{"key":"2021111718053264100_CIT0017","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties.","volume":"154","author":"Ingram","year":"2012","journal-title":"Vital Health Stat 2"},{"key":"2021111718053264100_CIT0018","volume-title":"Prevention of human immunodeficiency virus (HIV) infection: preexposure prophylaxis","author":"US Preventive Services Task Force","year":"2019"},{"key":"2021111718053264100_CIT0019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States.","volume":"73","author":"Van Handel","year":"2016","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"2021111718053264100_CIT0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/15332640.2016.1196629","article-title":"Sociodemographic and access-related correlates of health-care utilization among African American injection drug users: the BESURE study.","volume":"16","author":"Maragh-Bass","year":"2017","journal-title":"J Ethn Subst Abuse"},{"key":"2021111718053264100_CIT0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12954-017-0151-4","article-title":"Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU (\u201cI do\u201d) Care Collaborative.","volume":"14","author":"Stopka","year":"2017","journal-title":"Harm Reduct J"},{"key":"2021111718053264100_CIT0022","doi-asserted-by":"crossref","first-page":"e0233927","DOI":"10.1371\/journal.pone.0233927","article-title":"High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department.","volume":"15","author":"Anderson","year":"2020","journal-title":"PLoS One"},{"key":"2021111718053264100_CIT0023","article-title":"Rowley CF. High inpatient health care utilization and charges associated with injection drug use\u2013related infections: a cohort study, 2012\u20132015.","volume":"8:XXX\u2013XX","author":"Rapoport","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2021111718053264100_CIT0024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12019-007-0011-3","article-title":"Health-seeking behaviors and sexually transmitted diseases among adolescents attending an urban pediatric emergency department.","volume":"33","author":"Monroe","year":"2007","journal-title":"Compr Ther"},{"key":"2021111718053264100_CIT0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/PEC.0b013e3182767d7c","article-title":"Sexually transmitted infection prevalence in symptomatic adolescent emergency department patients.","volume":"28","author":"Goyal","year":"2012","journal-title":"Pediatr Emerg Care"},{"key":"2021111718053264100_CIT0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1783\/147118902101196658","article-title":"Screening for genital Chlamydia trachomatis in teenagers attending a family planning youth clinic: a prevalence study using a strand displacement assay on urine samples.","volume":"28","author":"Baird","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2021111718053264100_CIT0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mem.2000.105930","article-title":"Opportunistic urine ligase chain reaction screening for sexually transmitted diseases in adolescents seeking care in an urban emergency department.","volume":"36","author":"Embling","year":"2000","journal-title":"Ann Emerg Med"},{"key":"2021111718053264100_CIT0028","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5409\/wjcp.v6.i3.154","article-title":"Screening for asymptomatic chlamydia and gonorrhea in adolescent males in an urban pediatric emergency department.","volume":"6","author":"Maraynes","year":"2017","journal-title":"World J Clin Pediatr"},{"key":"2021111718053264100_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"2021111718053264100_CIT0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013.","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021111718053264100_CIT0031","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.drugalcdep.2006.09.022","article-title":"Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.","volume":"91","author":"Campbell","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"2021111718053264100_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2021111718053264100_CIT0033","doi-asserted-by":"crossref","first-page":"902","DOI":"10.7326\/M14-1981","article-title":"Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/8\/11\/ofab489\/41134342\/ofab489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/8\/11\/ofab489\/41134342\/ofab489.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T18:13:52Z","timestamp":1637172832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab489\/6425778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab489","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,11,1]]},"article-number":"ofab489"}}